Overview A Study of PMPA in HIV-Infected Patients Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary The purpose of this study is to see if it is safe and effective to give PMPA to HIV-infected patients. This study also examines how the body handles PMPA. Phase: Phase 1 Details Lead Sponsor: Gilead SciencesTreatments: Tenofovir